Acurx Pharmaceuticals Llc Stock Performance
| ACXP Stock | USD 2.76 0.27 10.84% |
The firm shows a Beta (market volatility) of 1.46, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Acurx Pharmaceuticals will likely underperform. At this point, Acurx Pharmaceuticals LLC has a negative expected return of -0.0462%. Please make sure to confirm Acurx Pharmaceuticals' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Acurx Pharmaceuticals LLC performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Acurx Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Acurx Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
Actual Historical Performance (%)
One Day Return 10.84 | Five Day Return (13.48) | Ten Year Return (98.25) | All Time Return (98.25) |
Last Split Factor 1:20 | Last Split Date 2025-08-05 |
1 | Meet the Companies - New to The Streets Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC | 10/10/2025 |
2 | Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens | 11/10/2025 |
3 | Acurx Pharmaceuticals, Inc. Q3 2025 Earnings Call Transcript | 11/13/2025 |
4 | Disposition of 3125 shares by Sailer Carl of Acurx Pharmaceuticals at 4.0 subject to Rule 16b-3 | 11/28/2025 |
5 | Acurx Pharmaceuticals Upgraded to Hold at Wall Street Zen | 12/29/2025 |
Acurx Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 429.00 in Acurx Pharmaceuticals LLC on October 7, 2025 and sell it today you would lose (153.00) from holding Acurx Pharmaceuticals LLC or give up 35.66% of portfolio value over 90 days. Acurx Pharmaceuticals LLC is currently does not generate positive expected returns and assumes 13.6237% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Acurx, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Acurx Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Acurx Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Acurx Pharmaceuticals LLC, and traders can use it to determine the average amount a Acurx Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0034
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ACXP |
Based on monthly moving average Acurx Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acurx Pharmaceuticals by adding Acurx Pharmaceuticals to a well-diversified portfolio.
Acurx Pharmaceuticals Fundamentals Growth
Acurx Stock prices reflect investors' perceptions of the future prospects and financial health of Acurx Pharmaceuticals, and Acurx Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Acurx Stock performance.
| Return On Equity | -2.91 | ||||
| Return On Asset | -0.96 | ||||
| Current Valuation | (151.2 K) | ||||
| Shares Outstanding | 2.09 M | ||||
| Price To Book | 1.58 X | ||||
| EBITDA | (14.1 M) | ||||
| Net Income | (14.1 M) | ||||
| Cash And Equivalents | 9.09 M | ||||
| Cash Per Share | 0.80 X | ||||
| Total Debt | 3.24 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 19.43 X | ||||
| Book Value Per Share | 2.02 X | ||||
| Cash Flow From Operations | (10.38 M) | ||||
| Earnings Per Share | (8.18) X | ||||
| Market Capitalization | 5.76 M | ||||
| Total Asset | 3.86 M | ||||
| Retained Earnings | (67.32 M) | ||||
| Working Capital | 615.12 K | ||||
About Acurx Pharmaceuticals Performance
Assessing Acurx Pharmaceuticals' fundamental ratios provides investors with valuable insights into Acurx Pharmaceuticals' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Acurx Pharmaceuticals is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.20) | (4.41) | |
| Return On Capital Employed | (26.37) | (25.05) | |
| Return On Assets | (4.20) | (4.41) | |
| Return On Equity | (26.37) | (25.05) |
Things to note about Acurx Pharmaceuticals LLC performance evaluation
Checking the ongoing alerts about Acurx Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Acurx Pharmaceuticals LLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Acurx Pharmaceuticals generated a negative expected return over the last 90 days | |
| Acurx Pharmaceuticals has high historical volatility and very poor performance | |
| Acurx Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (14.1 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Acurx Pharmaceuticals LLC currently holds about 9.09 M in cash with (10.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8. | |
| Acurx Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from thelincolnianonline.com: Acurx Pharmaceuticals Upgraded to Hold at Wall Street Zen |
- Analyzing Acurx Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Acurx Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Acurx Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Acurx Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Acurx Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Acurx Pharmaceuticals' stock. These opinions can provide insight into Acurx Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Acurx Stock Analysis
When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.